DEA Advances Schedule III Rescheduling to Final Rule Stage

DEA Publishes Final Rule on Schedule III Rescheduling

The DEA issued its final rule on marijuana rescheduling on August 19, 2026, marking the last procedural step before implementation. The agency bypassed a second notice-and-comment period, moving directly from the Notice of Proposed Rulemaking (NPRM) published in May 2024 to a binding final rule. This procedural leap compresses the timeline significantly. Prior estimates had projected a decision window extending into early 2027.

The final rule doesn't automatically reschedule marijuana. It establishes the DEA's official position and triggers a mandatory 30-day congressional review period under the Congressional Review Act. Barring legislative intervention, the rescheduling takes effect 30 days after publication in the Federal Register.

What Schedule III Means for State-Licensed Operators

Schedule III classification unlocks Section 280E tax relief for state-licensed cannabis businesses, allowing standard business expense deductions. Under current Schedule I rules, operators can't deduct rent, payroll, or marketing costs, creating effective tax rates exceeding 70 percent for many multi-state operators. Schedule III treatment restores ordinary income tax calculations, potentially saving mid-sized MSOs $5 million to $15 million annually.

Banking access doesn't change. Federal financial institutions remain barred from servicing cannabis accounts under the Bank Secrecy Act and anti-money-laundering statutes, which operate independently of the Controlled Substances Act scheduling framework. The SAFE Banking Act, stalled in Congress since 2019, remains the only legislative path to normalize banking for state-legal cannabis.

Michigan and Ohio Operators Face Uneven Impact

Michigan's mature recreational market stands to see immediate margin expansion, while Ohio's medical-only framework limits the upside. Michigan licensed 428 active adult-use retailers as of August 2026, according to the state Cannabis Regulatory Agency. These operators currently pay an average effective tax rate of 68 percent after 280E adjustments, per industry filings. Schedule III cuts that rate to roughly 25 percent—the standard corporate rate after state and local levies.

Ohio's medical program, which began sales in 2019 and added adult-use licensing in 2024, operates under a smaller footprint. Sixty-one active dispensaries statewide as of August 2026. The state's cultivator count remains capped at 28 licenses, creating a supply-constrained environment where tax savings translate less directly to consumer price relief. For context on how Ohio's regulatory structure has evolved, see the CannIntel topic hub on DEA Schedule III rescheduling.

Interstate Commerce Remains Federally Prohibited

Schedule III doesn't legalize interstate transport or commerce; marijuana remains a controlled substance under federal law. The Cole Memo, rescinded in 2018, had established prosecutorial forbearance for state-compliant operators, but that forbearance was never statutory. Schedule III rescheduling doesn't restore or replace it. Operators shipping product across state lines, even between two adult-use states, face federal trafficking charges carrying five-year mandatory minimums under 21 U.S.C. § 841.

This creates a persistent competitive moat for in-state vertically integrated operators and penalizes MSOs seeking supply-chain efficiencies. Michigan's vertical integration requirement mandates that retailers source at least 50 percent of inventory from in-house cultivation, insulating local operators from out-of-state price pressure even after rescheduling.

THCA and Hemp-Derived Cannabinoid Products in Legal Limbo

The final rule doesn't address THCA, delta-8 THC, or other hemp-derived intoxicating cannabinoids sold under the 2018 Farm Bill loophole. These products, which convert to delta-9 THC through decarboxylation or isomerization, occupy a gray zone between the Farm Bill's 0.3 percent delta-9 threshold and the DEA's total-THC enforcement posture. Schedule III rescheduling applies only to marijuana as defined by total THC content, not individual cannabinoid profiles.

Michigan and Ohio have taken divergent approaches. Michigan's Cannabis Regulatory Agency issued an advisory in July 2026 stating that THCA flower exceeding 0.3 percent total THC requires a state cannabis license. Ohio's Division of Cannabis Control hasn't issued equivalent guidance, leaving THCA products available in gas stations and hemp shops alongside CBD. Expect enforcement to vary.

What Happens Next: Congressional Review and Effective Date

Congress has 30 legislative days to pass a joint resolution of disapproval blocking the rule; absent that, rescheduling becomes effective 30 days after Federal Register publication. The Congressional Review Act requires both chambers to pass a disapproval resolution and the president to sign it—a high bar in a divided Congress. No cannabis-related CRA resolution has ever advanced past committee.

If the rule survives congressional review, the effective date falls in late September 2026. State-licensed operators can begin claiming standard business deductions for tax year 2026, with amended returns available for prior years still within the statute of limitations. The IRS hasn't issued guidance on transition mechanics, but tax practitioners expect a flood of amended 1120 filings in Q4 2026.

The next signal: IRS guidance on 280E transition rules, expected within 60 days of the effective date. Until then, this remains unsettled ground for operators planning capital deployment around post-rescheduling tax savings.